The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.

MLA

Djavan, Bob, et al. “The Short-Term Use of Erythropoetin-Stimulating Agents: Impact on the Biochemical Recurrence of Prostate Cancer.” BJU International, vol. 108, no. 10, Nov. 2011, pp. 1582–87. EBSCOhost, https://doi.org/10.1111/j.1464-410X.2011.10173.x.

APA

Djavan, B., Laze, J., Eckersberger, E., Finkelstein, J., Agalliu, I., & Lepor, H. (2011). The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. BJU International, 108(10), 1582–1587. https://doi.org/10.1111/j.1464-410X.2011.10173.x

Chicago

Djavan, Bob, Juliana Laze, Elisabeth Eckersberger, Julia Finkelstein, Ilir Agalliu, and Herbert Lepor. 2011. “The Short-Term Use of Erythropoetin-Stimulating Agents: Impact on the Biochemical Recurrence of Prostate Cancer.” BJU International 108 (10): 1582–87. doi:10.1111/j.1464-410X.2011.10173.x.